Vir Biotechnology (VIR) EBT Margin (QoQ) (2018 - 2026)
Vir Biotechnology (VIR) EBT Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.28 Mn |
| Dec 31, 2025 | 6.78 Mn |
| Sep 30, 2025 | -5.88 Mn |
| Jun 30, 2025 | -513,678.00 |
| Mar 31, 2025 | -314,316.00 |
| Dec 31, 2024 | 812,634.00 |
| Sep 30, 2024 | -442,300.00 |
| Jun 30, 2024 | -442,354.00 |
| Mar 31, 2024 | 59,362.00 |
| Dec 31, 2023 | 559,463.00 |
| Sep 30, 2023 | -110,927.00 |
| Jun 30, 2023 | -497,728.00 |
| Mar 31, 2023 | 7,946.00 |
| Dec 31, 2022 | -36,503.00 |
| Sep 30, 2022 | 63,339.00 |
| Jun 30, 2022 | -65,006.00 |
| Mar 31, 2022 | 764.00 |
| Dec 31, 2021 | -3,973.00 |
| Sep 30, 2021 | 7,014.00 |
| Jun 30, 2021 | 857,497.00 |